BSE Live
Oct 10, 16:01Prev. Close
172.55
Open Price
175.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 10, 15:58Prev. Close
173.15
Open Price
175.24
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Profit & Loss account of Nath Bio-Genes (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 278.90 | 229.39 | 191.26 | 168.94 | 162.11 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 278.90 | 229.39 | 191.26 | 168.94 | 162.11 | |
Total Operating Revenues | 279.89 | 230.93 | 191.65 | 169.87 | 162.11 | |
Other Income | 1.82 | 2.27 | 0.94 | 0.52 | 0.85 | |
Total Revenue | 281.71 | 233.20 | 192.59 | 170.38 | 162.95 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Purchase Of Stock-In Trade | 7.35 | 5.49 | 2.71 | 1.97 | 4.36 | |
Operating And Direct Expenses | 146.28 | 108.21 | 64.02 | 47.73 | 73.60 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -48.25 | -30.46 | 6.79 | 10.40 | -24.42 | |
Employee Benefit Expenses | 18.74 | 16.43 | 13.66 | 13.74 | 13.63 | |
Finance Costs | 6.55 | 5.20 | 10.31 | 9.66 | 6.23 | |
Depreciation And Amortisation Expenses | 1.45 | 1.45 | 0.95 | 3.03 | 3.90 | |
Other Expenses | 101.08 | 88.01 | 64.10 | 67.10 | 70.41 | |
Total Expenses | 233.20 | 194.33 | 162.54 | 153.63 | 147.72 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 48.51 | 38.87 | 30.05 | 16.75 | 15.23 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 48.51 | 38.87 | 30.05 | 16.75 | 15.23 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 0.16 | 0.11 | 0.45 | 0.46 | 0.86 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.03 | 0.14 | -0.01 | 0.01 | 0.19 | |
Tax For Earlier Years | -2.17 | 0.19 | 0.19 | 0.00 | 0.00 | |
Total Tax Expenses | -1.98 | 0.43 | 0.64 | 0.47 | 1.05 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 50.48 | 38.43 | 29.42 | 16.28 | 14.19 | |
Profit/Loss From Continuing Operations | 50.48 | 38.43 | 29.42 | 16.28 | 14.17 | |
Profit/Loss For The Period | 50.48 | 38.43 | 29.42 | 16.28 | 14.17 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 26.33 | 20.18 | 17.83 | 10.17 | 8.85 | |
Diluted EPS (Rs.) | 26.33 | 20.18 | 17.83 | 10.17 | 8.85 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
14.07.2025
Nath Bio-Genes Standalone June 2025 Net Sales at Rs 280.17 crore, up 14.88% Y-o-Y
14.07.2025
Nath Bio-Genes Consolidated June 2025 Net Sales at Rs 283.70 crore, up 16.33% Y-o-Y
02.05.2025
Nath Bio-Genes Consolidated March 2025 Net Sales at Rs 51.97 crore, up 20.75% Y-o-Y
02.05.2025
Nath Bio-Genes Standalone March 2025 Net Sales at Rs 49.37 crore, up 14.71% Y-o-Y
14.07.2025
Nath Bio-Genes Standalone June 2025 Net Sales at Rs 280.17 crore, up 14.88% Y-o-Y
14.07.2025
Nath Bio-Genes Consolidated June 2025 Net Sales at Rs 283.70 crore, up 16.33% Y-o-Y
02.05.2025
Nath Bio-Genes Consolidated March 2025 Net Sales at Rs 51.97 crore, up 20.75% Y-o-Y
02.05.2025
Nath Bio-Genes Standalone March 2025 Net Sales at Rs 49.37 crore, up 14.71% Y-o-Y